By GlobeNewswire, March 08, 2013, 11:50:00 AM EDT
Conference Call Scheduled for March 14, 2013
HACKENSACK, N.J., March 8, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR) announced today that it will report its financial results for the third quarter, on Thursday, March 14, 2013 at 8:30 AM ET. To participate in the conference call, please dial use the information below:
Participant Dial-in Numbers:
U.S. Toll Free: 800-874-4559
Canadian Toll Free: 800-696-0876
International Toll: 302-607-2019
Verbal Passcode (to be given to the operator): Champions Oncology
About Champions Oncology, Inc.
Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The Company's TumorGraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the TumorGrafts in a manner that preserves the biological characteristics in order to determine the efficacy of a treatment regimen. The Company uses this technology to offer solutions for Personalized Oncology Solutions, which guides the development of personalized treatment plans, and Translational Oncology Solutions, which assists pharmaceutical and biotechnology companies seeking personalized approaches to drug development to lower the cost and increase the speed of drug development.
For more information, visit www.championsoncology.com
This press release may contain "forward-looking statements" (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties. Champions Oncology generally uses words such as "believe," "may," "could," "will," "intend," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements. One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors. See Champions Oncology's Form 10-K for the fiscal year ended April 30, 2012 for a discussion of such risks, uncertainties and other factors. Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations. The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.
CONTACT: Gary GemignaniChampions Oncology, Inc.
GGemignani@championsoncology.comLauren KwiecinskiThe Trout Group LLC
Source: Champions Oncology